Bio Equity’s investment strategy is focused on direct secondary and annex fund investments that meet the needs and challenges faced by investors in healthcare companies.

Investment Considerations

Sector

• Medical devices, diagnostics, specialty pharma, biotech, healthcare IT and healthcare services

Stage

• Mid to later stage portfolios and companies

Size

• Single company interests $1 million or greater
• Portfolios up to $250 million

Type

• Equity, debt (including distressed)